Abstract
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to SurgeryReferences
- Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats.Circulation. 1998; 97: 1382-1391
- Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha.Circ Res. 1997; 81: 627-635
- Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice.J Card Fail. 1997; 3: 117-124
- Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha.Circulation. 1998; 97: 1375-1381
- Adenosine decreases post-ischemic myocardial TNFα anti-inflammatory implications for preconditioning and transplantation.Immunology. 1997; 92: 472-477
- Adenosine reduces cardiac TNF-α production and human myocardial injury following ischemia-reperfusion.J Surg Res. 1998; 76: 117-123
- Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge.J Immunol. 1993; 151: 389-396
- Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice.J Immunol. 1996; 157: 4634-4640
- Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo.Cell Mol Biol. 1997; 43: 345-349
- Adenosine increases interleukin 6 release and decreases tumor necrosis factor release from rat adrenal zona glomerulosa cells, ovarian cells, anterior pituitary cells, and peritoneal macrophages.Cytokine. 1997; 9: 187-198
- Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-alpha.Circ Res. 1998; 82: 47-56
- NF-κB: ten years after.Cell. 1996; 87: 13-20
- The NF-κB and IκB proteins: new discoveries and insights.Annu Rev Immunol. 1996; 14: 649-683
- The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.Biochim Biophys Acta. 1991; 1072: 129-157
- Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells.Free Rad Res Comms. 1992; 17: 221-237
- Rapid and preferential activation of the c-jun gene during the mammalian UV response.Mol Cell Biol. 1991; 11: 2804-2811
- Hydrogen peroxide and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant responsive factor.EMBO J. 1993; 12: 2005-2015
- Early activation of transcription factor NF-κB during ischemia in perfused rat heart.Am J Physiol. 1999; 276: H543-H552
- Protooncogene expression I porcine myocardium subjected to ischemia and reperfusion.Circ Res. 1992; 71: 1351-1360
- Gene expression during myocardial adaptation to ischemia and reperfusion.Ann NY Acad Sci. 1994; 723: 292-307
- Induction of nuclear factor κB and activation protein 1 in postischemic myocardium.FEBS Lett. 1997; 401: 30-34
- Effect of temperature during potassium arrest on myocardial metabolism and function.J Thorac Cardiovasc Surg. 1982; 84: 243-249
- Therapeutic modification of nuclear factor κB binding activity and tumor necrosis factor-α gene expression during acute biliary pancreatitis.Am Surg. 1997; 63: 1036-1044
- Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1→3) β–D-glucan increases long-term survival in polymicrobial sepsis.Surgery. 1999; 126: 54-65
- Differential regulatory effects of adenosine on cytokine release by activated human monocytes.J Immunol. 1994; 153: 4159-4168
- Suppression of lipopolysaccharide-stimulated release of tumor necrosis factor by adenosine: evidence for A2 receptors on rat Kupffer cells.Hepatology. 1994; 19: 1445-1452
- Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells.Am J Physiol. 1996; 270: C522-C529
- Expression and regulation of adhesion molecules in cardiac cells by cytokines, response to acute hypoxia.Circ Res. 1998; 82: 576-586
- In vivo transcription of cis element “decoy” against nuclear factor-kappa B binding site prevents myocardial infarction.Nat Med. 1997; 3: 894-899
- A novel strategy for myocardial protection using in vivo transfection of cis element ‘decoy' against NF-κB binding site: evidence for a role of NF-κB in ischemia-reperfusion injury.Circulation. 1997; 96: II-280-II-285
- Inhibition of nuclear factor κB attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium.Biochim Biophys Acta. 1998; 1406: 91-106
- Cytokine mRNA expression in postischemic/reperfusion myocardium.Am J Pathol. 1995; 146: 419-428
- Myocardial ischemia before reperfusion activates cardiocyte nuclear factor kappa B and induces production of tumor necrosis factor alpha.Surg Forum. 1998; : 231-233
- Promoter analysis of the gene encoding the IκBα/MAD3 inhibitor of NF-κB: positive regulation by members of the rel/NF-κB family.EMBO J. 1993; 12: 5043-5049
- Autoregulation of IκBα activity.Proc Natl Acad Sci USA. 1994; 91: 28-32
- Activation of AP-1 and of nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia.Mol Cell Biol. 1994; 14: 5997-6003
- The genomic response of tumor cells to hypoxia and reoxygenation differential activation of transcription factors AP-1 and NF-κB.Eur J Biochem. 1995; 234: 632-640
- Induction of c-fos and c-jun gene expression by phenolic antioxidants.Mol Endocrinol. 1993; 7: 1596-1602
- Oxidantinduced activations of nuclear factor-kappa B and activator protein-1 in cardiac myocytes.Cell Mol Biol Res. 1995; 41: 189-197
- Protective effects of adenosine in myocardial ischemia.Circulation. 1992; 85: 893-904
- Adenosine, an endogenous anti-inflammatory agent.J Appl Physiol. 1994; 76: 5-13
- Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1.Proc Natl Acad Sci USA. 1994; 91: 1672-1676
- Inhibition of TNF-α expression by adenosine: role of A3 adenosine receptors.J Immunol. 1996; 156: 3435-3442
- The role of adenosine in cardioplegia.in: Cardioplegia: Current Concepts and Controversies. TX: RG Landers, Austin1993: 42-51
Article info
Publication history
Footnotes
*Supported in part by NIH Grant HL54286, a VA Merit Review Grant, and a Cardiovascular Research Institute Grant of East Tennessee State University.
**Reprint requests: Race L. Kao, PhD, Department of Surgery, James H. Quillen College of Medicine, East Tennessee State University, P.O. Box 70575, Johnson City, TN 37614-0575.